Christiana Care seeks FDA approval for CRISPR cancer trial - Technical.ly Delaware

Sciences

Apr. 30, 2019 4:37 pm

Christiana Care seeks FDA approval for CRISPR cancer trial

The gene editing tool could potentially save lives.
Gene editing could be used to fight cancer before long.

Gene editing could be used to fight cancer before long.

(Screenshot via YouTube)

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), the gene-editing tool, has been the subject of countless debates on the ethical use of a technology that can actually alter DNA — with some foreseeing a dystopia of custom-ordered babies and miniature giraffes as pets.

Less dystopian are the potential medical benefits of CRISPR, which is why the Christiana Care Health System’s Gene Editing Institute is in the process of developing its first clinical trial that would use CRISPR on patients, after conducting successful lab trials. (You can read the December 2018 proof of concept paper on Molecular Therapy Oncolytics.)

The institute recently filed a preliminary investigational new drug application (IND) with the U.S. Food and Drug Administration. If approved, the trial, which focuses on treatment of  KRAS-positive non-small cell lung cancer, would have cleared a major hurdle in starting the trial.

“This exciting study represents a trio of firsts,” said Nicholas J. Petrelli, M.D., FACS, medical director of Christiana Care’s Helen F. Graham Cancer Center & Research Institute, in a statement. “It will be the first lung cancer clinical trial carried out by a gene editing program embedded in a community cancer center. While our Gene Editing Institute has a great deal of translational research experience, this will be its first study to move scientific discovery toward an IND application.

“And, it will also be the first time that we will be investigating technology that was grown organically at the Gene Editing Institute.”

You can learn more about CRISPR here:

Advertisement

-30-
BECOME A CONTRIBUTOR TO THE JOURNALISM FUND TO COMMENT
Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

UD-led program receives $23.5M for biomed research

What is Delaware’s next big thing?

Prelude Therapeutics lands $60 million in Series B funding

SPONSORED

Delaware

Mastering the ‘halo effect’ in tech recruiting

Philadelphia

Vistar Media

Sr. Software Engineer

Apply Now

Philadelphia

Vistar Media

Front End Engineer

Apply Now

Philadelphia, PA - Center City

Odessa

Business Architect

Apply Now

On DuPont’s rebirth day, biotech leaders answer the question ‘Why Delaware?’

Cape Henlopen High School will incorporate coastal engineering into its curriculum

These Sussex Tech students are headed to the national Future Health Professionals championships

SPONSORED

Delaware

Verizon is looking for the brightest ideas on how to use its 5G technology

Offsite

Philadelphia Home

Social Media Catalyst

Apply Now

Baltimore, Brooklyn, D.C., Delaware, Philadelphia

Vistar Media

Software Engineer

Apply Now

Malvern, PA

Vanguard

Senior Front End Engineer – CX Journey Lab

Apply Now

Sign-up for daily news updates from Technical.ly Delaware

Do NOT follow this link or you will be banned from the site!